In tg5XFAD mice, an Alzheimer’s disease model, RNS60 treatment suppress neuronal apoptosis, attenuate tau phosphorylation, inhibit glia activation, reduces Aβ plaques aggregation and protects memory [28]. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.